Treatment-Specific Composition of Gut Microbiota Is Associated with Disease Remission in a Pediatric Crohn’s Disease Cohort
D. Sprockett, N. Fischer, R. S. Boneh, D. Turner, J. Kierkus, M. Sladek, J. Escher, E. Wine, B. Yerushalmi, J. A. Dias, R. Shaoul, M. Kori, S. Snapper, S. Holmes, A. Bousvaros, , D. A. Relman
This study examines how gut microbiota changes with metronidazole and metronidazole plus azithromycin treatments in pediatric Crohn’s disease and finds that microbiota profiles can predict disease remission.
bioRxiv · May 19, 2019Microbiology